𝔖 Bobbio Scriptorium
✦   LIBER   ✦

1089 Improved safety of capecitabine vs bolus 5-FU/leucovorin (LV) as adjuvant therapy for colon cancer (the X-ACT phase III study)

✍ Scribed by Nowacki, M.; Kröning, H.; Cervantes, A.; Husseini, F.; McKendrick, J.; Schuller, J.; Twelves, C.; Wong, A.; Zaluski, J.; Douillard, J.-Y.


Book ID
123385727
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
164 KB
Volume
1
Category
Article
ISSN
1359-6349

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES